[1]罗顺利,许泽广,梁春正.复合式小梁切除术联合康柏西普治疗新生血管性青光眼[J].眼科新进展,2016,36(11):1076-1078.[doi:10.13389/j.cnki.rao.2016.0287]
　LUO Shun-Li,XU Ze-Guang,LIANG Chun-Zheng.Compound trabeculectomy with conbercept for neovascular glaucoma[J].Recent Advances in Ophthalmology,2016,36(11):1076-1078.[doi:10.13389/j.cnki.rao.2016.0287]
点击复制

复合式小梁切除术联合康柏西普治疗新生血管性青光眼
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
36卷
期数:
2016年11期
页码:
1076-1078
栏目:
应用研究
出版日期:
2016-11-05

文章信息/Info

Title:
Compound trabeculectomy with conbercept for neovascular glaucoma
作者:
罗顺利; 许泽广; 梁春正
466000　河南省周口市，周口市眼科医院
Author(s):
LUO Shun-Li ; XU Ze-Guang ;  LIANG Chun-Zheng
Eye Hospital of Zhoukou, Zhoukou 466000 , Henan Province , China
关键词:
复合式小梁切除术; 康柏西普; 新生血管性青光眼; 睫状体冷凝术
Keywords:
compound trabeculectomy ;  conbercept ;  neovascular glaucoma ;  cyclocryotherapy
分类号:
Ｒ７７５
DOI:
10.13389/j.cnki.rao.2016.0287
文献标志码:
A
摘要:
目的　观察复合式小梁切除术联合康柏西普对新生血管性青光眼的疗效。方法　５６例（５６眼）新生血管性青光眼患者根据治疗方法不同分为Ａ组和Ｂ组，Ａ组给予康柏西普玻璃体内注射后行复合式小梁切除术，Ｂ组给予睫状体冷凝术治疗。对两组患者术后视力、眼压、手术成功率和并发症情况进行观察，并进行统计学分析。结果　术后１个月，Ａ组视力提高者１０眼（３５．７％），不变者１６眼（５７．１％），下降者２眼（７．２％）；Ｂ组视力提高者３眼（１０．７％），不变者１７眼（６０．７％），下降者８眼（２８．６％）；两组视力提高率间差异有统计学意义（Ｐ＜０．０５），Ａ组视力提高率较Ｂ组高。Ａ组手术成功率为９２．９％，显著高于Ｂ组（７８．６％），差异有统计学意义（Ｐ＜０．０５）。两组术后１ｄ、２周、３个月眼压与术前相比均显著下降，差异均有统计学意义（均为Ｐ＜０．０５）；术前两组眼压差异无统计学意义（Ｐ＞０．０５），术后各时间点两组眼压比较差异均有统计学意义（均为Ｐ＜０．０５），Ａ组均显著低于Ｂ组。Ａ组并发症发生率为２１．４％，显著低于Ｂ组（７５．０％），差异有统计学意义（Ｐ＜０．０５）。结论　复合式小梁切除术联合康柏西普治疗新生血管性青光眼疗效好、并发症少、安全性高。
Abstract:
Objective To observe the clinical effects of compound trabeculectomy with conbercept for neovascular glaucoma. Methods A total of 56 patients ( 56 eyes) with neovascular glaucoma were divided into two groups : Group A ( observation group) and group B ( control group ) , by random number method. The observation group was treated with compound trabeculectomy and conbercept. Control group was treated with cyclocryotherapy. The changes on visual acuity ,intraocular pressure ( IOP) and complication were observed after operation. Results Postoperative visual acuity at I month improved in 10 eyes ( 35. 7% ) in group A, which was sigruficantly more than that in group B (3 eyes , 10. 7% ) (P <0. 05 ) ;And decreased in 2 eyes (7. 2% ) in group A,which was significantly less than that in group B ( 8 eyes,28. 6% ) (P < 0. 05 ) . The Successful rate in group A and B were 92. g% and 78. 6% ,respectively , there was statistical difference (P < 0. 05 ). At the postoperative I day,2 weeks and 3 months , IOP in two groups decreased significantly and there were statistical differences compared with that before treatment ( all P < 0. 05 ) . The incidence of complication in group A was 21. 4% .which was sigruficantly lower than that of group B ( 75. 0% ) (P < 0. 05 ) . Conclusion Compound trabeculectomy with conbercept for neovascular glaucoma can improve visual acuity , reduce IOP . and relieve symptoms with high safety.

相似文献/References:

[1]王勤 罗顺利.不同抗青光眼手术后浅前房发生率比较及原因分析[J].眼科新进展,2012,32(5):000.
[2]代应辉 李娟 王剑锋 秦梅 高自清.前部视网膜、睫状体冷凝联合复合式小梁切除术治疗新生血管性青光眼的临床研究[J].眼科新进展,2012,32(6):000.
[3]张娣,张玲,杨静,等.玻璃体内注射康柏西普联合手术及全视网膜光凝治疗新生血管性青光眼[J].眼科新进展,2015,35(12):1170.[doi:10.13389/j.cnki.rao.2015.0320]
　ZHANG Di,ZHANG Ling,YANG Jing,et al.Intravitreal injection of conbercept combined with operation and panretinal photocoagulation for neovascular glaucoma[J].Recent Advances in Ophthalmology,2015,35(11):1170.[doi:10.13389/j.cnki.rao.2015.0320]
[4]李娜,张杰,高荣玉,等.单次注射康柏西普治疗渗出型AMD患者RPE隆起面积与容积变化[J].眼科新进展,2016,36(2):172.[doi:10.13389/j.cnki.rao.2016.0047]
　LI Na,ZHANG Jie,GAO Rong-Yu,et al.Changes of retinal pigment epithelium uplift area and volume in exudative age-related macular degeneration after once injection of conbercept[J].Recent Advances in Ophthalmology,2016,36(11):172.[doi:10.13389/j.cnki.rao.2016.0047]
[5]高郁玮,张舒心,孙丽,等.玻璃体切割术后（水眼）继发青光眼的手术治疗策略[J].眼科新进展,2016,36(3):254.[doi:10.13389/j.cnki.rao.2016.0068]
　GAO Yu-Wei,ZHANG Shu-Xin,SUN Li,et al.Surgical strategies for glaucoma secondary to vitrectomy[J].Recent Advances in Ophthalmology,2016,36(11):254.[doi:10.13389/j.cnki.rao.2016.0068]
[6]王琛,李东豪,闻毅颐.玻璃体内注射康柏西普联合周边视网膜选择性光凝治疗视网膜静脉阻塞继发黄斑水肿的疗效及安全性[J].眼科新进展,2016,36(5):471.[doi:10.13389/j.cnki.rao.2016.0126]
　WANG Chen,LI Dong-Hao,WEN Yi-Yi.Intravitreal injection of conbercept combined with selective peripheral retinal photocoagulation for macular edema secondary to retinal vein occlusion[J].Recent Advances in Ophthalmology,2016,36(11):471.[doi:10.13389/j.cnki.rao.2016.0126]
[7]王玮,徐玲娟,蔡苏博,等.角膜基质及结膜下单次注射康柏西普治疗角膜新生血管的疗效及安全性[J].眼科新进展,2016,36(8):725.[doi:10.13389/j.cnki.rao.2016.0192]
　WANG Wei,XU Lin-Juan,CAI Su-Bo,et al.Efficacy and safety of one dose intrastromal and subconjunctival conbercept injection for corneal neovascularization[J].Recent Advances in Ophthalmology,2016,36(11):725.[doi:10.13389/j.cnki.rao.2016.0192]
[8]史志洁,张金嵩,吕晓贝.玻璃体内注射康柏西普联合手术治疗伴玻璃体积血的新生血管性青光眼[J].眼科新进展,2016,36(8):751.[doi:10.13389/j.cnki.rao.2016.0200]
　SHI Zhi-Jie,ZHANG Jin-Song,LV Xiao-Bei.Intravitreal injection of conbercept and surgical treatment for neovascular glaucoma combined with vitreous hemorrhage[J].Recent Advances in Ophthalmology,2016,36(11):751.[doi:10.13389/j.cnki.rao.2016.0200]
[9]吴若欣,徐洁慧,温积全,等.玻璃体内注射康柏西普对渗出性老年性黄斑变性患者脉络膜厚度的影响[J].眼科新进展,2016,36(12):1172.[doi:10.13389/j.cnki.rao.2016.0312]
　WU Ruo-Xin,XU Jie-Hui,WEN Ji-Quan,et al.Effects of intravitreal conbercept injections on choroidal thickness in exudative age-related macular degeneration[J].Recent Advances in Ophthalmology,2016,36(11):1172.[doi:10.13389/j.cnki.rao.2016.0312]
[10]薛鹏程,游志鹏,付书华,等.23G玻璃体切割术前、术中辅助玻璃体内注射康柏西普治疗增生型糖尿病视网膜病变（PDR）的疗效分析[J].眼科新进展,2017,37(5):458.[doi:10.13389/j.cnki.rao.2017.0116]
　XUE Peng-Cheng,YOU Zhi-Peng,FU Shu-Hua,et al.Preoperative and intraoperative adjunctive intravitreal conbercept in 23G vitrectomy for proliferative diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(11):458.[doi:10.13389/j.cnki.rao.2017.0116]

更新日期/Last Update: 2016-11-29